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TRANSCRIPTOMIC ANALYSIS OF DIETARY HYPOPHOSPHATEMIA SHOWS 
DOWNREGULATED OXIDATIVE METABOLISM IN FRACTURE CALLUS TISSUES 
DEVEN CARROLL 
 
ABSTRACT 
Phosphate deficiency mimics Vitamin D deficiency and generates a rachitic 
state that impairs the ability of bone to mineralize and delays fracture healing. 
Previous studies have shown that hypophosphatemia alters many biological 
functions, and oxidative phosphorylation was the top biological process that was 
predicted affected by this perturbation.  The goals of this study were to characterize 
the temporal mRNA expression for genes associated with oxidative phosphorylation 
and determine if phosphate deficiency more broadly altered the expression of genes 
associated with intermediate metabolism during fracture healing.   
Three in bred strains of skeletally mature male mice had stabilized fractures 
made in the right femur. The experimental group (Pi) was fed a low phosphate diet 
starting two days before fracture and continued for 16 days after which, a normal 
diet was re-introduced.  The control group (Ctrl) was fed a normal diet throughout 
the study. RNA was extracted from fracture calluses and the RNA was quantified by 
microarray analysis. Analysis of covariance (ANCOVA) identified genes that were 
differentially expressed between the Pi and Ctrl groups (q-value ≤ 0.005), and 
analysis was performed on a subset of 577 genes related to the central elements of 
intermediate metabolism that were identified using the Kyoto Encyclopedia of 
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Genes and Genomes (KEGG). To categorize genes that have similar temporal 
responses to the phosphate perturbation, the ratio of Pi/Ctrl expressions for each 
strain was independently clustered using normal mixtures method. These clusters 
were compared across the three strains to ascertain which groups of genes 
responded together in all three strains, and which biological functions bifurcated 
due to genetic variation between the strains.  
Oxidative phosphorylation and the tricarboxylic acid pathways showed the 
tightest temporal control in response to dietary phosphate restriction across all 
strains of mice.  Analysis of the temporal profile showed the response to phosphate 
was strain dependent with the B6 strain showing the strongest response to Pi 
restriction. The re-introduction of phosphate also restored and/or abolished the 
delay in oxidative phosphorylation expression in a strain specific manner. AJ and C3 
strains showed more similar rebounding profiles compared to the B6 stain.  
Additionally, it was found that Complex IV was affected by the phosphate deficient 
diet in manner different from the other components of ETC.  Some intermediate 
metabolic pathways that also appeared to be affected in similar manners across 
multiples strains included glycolysis, and arginine and proline metabolism. 
Overlaying these various functions, temporal coordination was observed and 
suggests the functions may be mediated by a common upstream regulator. Further 
investigation of this potential upstream regulator can help to better describe the 
mechanisms that cause a delayed fracture healing in a phosphate deficient state. 
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1 INTRODUCTION 
Bone fractures make up the largest proportion of non-fatal medical cases and 
approximately $34 billion was spent to care for patients who had experienced a fall 
and bone fracture in 2013 (CDC, 2015). Almost 10% of fractures do not heal 
normally (Einhorn & Gerstenfeld, 2015). Some of these malunions and nonunions 
are due to external factors like diabetes or obesity (Rodriguez et al., 2014). It is 
important to uncover the molecular mechanisms that regulate the process of 
fracture healing and to identify where and how diseases interfere with bone 
regeneration.  
Fracture healing is a unique process because it is truly regenerative and does 
not form scar tissue like soft tissues in the body and has many parallels with bone 
formation during embryological skeletogenesis (Ferguson, Alpern, Miclau, & Helms, 
1999).  Skeletogenesis has two main processes for bone formation: 
intramembranous and endochondral ossification. 
The flat bones (e.g. mandible, scapulae, sternum) are created through 
intramembranous ossification. A distinct characteristic of intramembranous 
ossification is the direct formation of bone through the condensation of 
mesenchymal stem cells (MSCs) that are in a highly vascular environment. Around 
centers of ossification, sheets of condensed MSCs differentiate into osteoprogenitor 
cells, then osteoblasts. These osteoblasts orient themselves apically towards the 
center of ossification and basally towards blood vessels that are forming in the 
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region (Figure 2). These osteoblasts first secrete collagen and osteoid 
(unmineralized organic component of bone matrix) to build up an unmineralized 
extracellular matrix (ECM). Subsequently, the osteoblasts release extracellular 
vesicles to mineralize the matrix around them, encasing themselves within the 
newly formed primary (woven) bone.  Blood vessels bring in monocytes that 
differentiate into osteoclasts that will help to remodel the newly formed bone. New 
MSCs continue to condense into sheets around this newly formed bone, 
differentiate, and lay down another layer of bone. This cycle continues until the flat 
bone is formed (Dimitriou, Tsiridis, & Giannoudis, 2005; Standring, 2016). 
Long bones of the appendicular skeleton and the vertebrae bodies of the axial 
skeleton go through endochondral ossification, illustrated in Figure 1. Endochondral 
bone formation is characterized by condensation of mesenchymal stem cells (MSCs) 
that differentiate into chondrocytes that create an avascular hyaline cartilage 
template for bone formation (Figure 1A). Around this cartilaginous template, a 
vascular sheet of condensed MSCs forms the periosteum. The chondrocytes begin to 
proliferate at the center of this template expanding the longitudinal dimension of 
the cartilaginous template. Then the chondrocytes will hypertrophy by 
accumulating glycogen and large vacuoles in their cytoplasm (Figure 1) (Standring, 
2016). 
 3 
 
 
Figure 1 Endochondral Bone Formation 
Illustration shows the progression of endochondral bone formation. A histology image of Stage F 
is shown in Figure 2 to highlight the stages of chondrocyte development. 
Adapted from Standring et al., 2016 
Simultaneously, the MSCs at the center of the periosteum differentiate into 
osteoprogenitor cells and then osteoblasts that create the periosteal collar via 
intramembranous ossification, thus establishing the primary ossification center (the 
first location where ossification will begin) – highlighted in Figure 1-C in dark 
purple. This periosteal collar allows for blood vessels to invade the hypertrophic 
chondrocytes, bringing in osteoclasts and osteoblasts (Figure 1-D). The 
hypertrophic chondrocytes subsequently undergo apoptosis and are resorbed by 
osteoclasts. Simultaneously, osteoblasts lay down osteoid, collagen and eventually 
release extracellular vesicles to form bone in place of the cartilage (Bronner, Farach-
Carson, & Roach, 2010; Clarke, 2008; Colnot, 2005; Standring, 2016). 
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Figure 2 Comparison of Intramembranous and Endochondral Bone Formation 
A. Intramembranous ossification of human nasal bone at 7 months. M indicates bone matrix and 
the arrows are pointing to osteoblasts that are secreting osteoid (light pink border surrounding the 
bone matrix). B. Histology showing the primary stages of chondrocyte maturation and 
ossification during endochondral bone formation. G: Proliferative Chondrocyte Growth Zone, G: 
Hypertrophic Chondrocyte Zone, O: Chondrocyte Apoptosis and Ossification, R: Bone 
Remodeling Zone. Adapted from Standring et al., 2016 
1.1 Fracture Healing 
To regenerate bone after a fracture, the fracture healing process reiterates 
many of the same mechanisms that occur during skeletogenesis (Ferguson et al., 
1999; Marsell & Einhorn, 2011). Indirect (secondary) is most common form of 
fracture healing and incorporates both endochondral and intramembranous 
ossification (Gerstenfeld et al., 2006; Grimes, Jepsen, Fitch, Einhorn, & Gerstenfeld, 
2011).  
The fracture healing process can be viewed on many different levels 
depending on the level of detail that is being investigated. From a broad view, this 
highly orchestrated process can be illustrated by two parallel timelines illustrated in 
Figure 3: the metabolic timeline (highlighted in blue) and the biological timeline (in 
brown) (Hankenson, Zimmerman, & Marcucio, 2014).  
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Figure 3 Phases of Fracture Healing Illustration 
Illustration shows the progression of fracture healing. Below the panels are estimates for the 
metabolic phases (highlighted in blue) and biological phases (highlighted in brown). 
Adapted from Einhorn et al., 2014 
The metabolic timeline provides a macroscopic overview of fracture healing 
contrasting the times bone is being generated (anabolic phases) and resorbed 
(catabolic phases). Fracture healing begins with the anabolic phases that generally 
consists of the following processes: (i) formation of a blood clot at the site of injury, 
(ii) an immune inflammatory response, (iii) the recruitment of mesenchymal stem 
cells that differentiate into chondrocytes and osteoblasts, (iv) the creation of 
cartilage and primary (woven) bone to form a soft and hard callus, respectively, (iv) 
the simultaneous recruitment of systemic stem cells to the site of injury to create 
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new vessels for the injured bone, and finally (v) the establishment of secondary, 
lamellar bone following prerequisite catabolic processes (Hankenson et al., 2014). 
The catabolic phase has substantial overlap with the anabolic phase, during which 
both formation and resorption of bone are simultaneously occurring (Hankenson et 
al., 2014).  Key characteristics of the catabolic phase include: (i) osteoclasts 
reabsorbing the cartilage from soft callus, (ii) resorbing any primary bone that had 
been laid down during intramembranous or late stages of endochondral ossification, 
and (iii) reforming the structures of the original bone including: the microstructure 
of the outer cortical layer and the hallowing out of the bone marrow space 
(Hankenson et al., 2014).  Hankenson et al assembled a graphical analysis (Figure 4) 
that we will use road map to explore the stages of fracture healing to highlight the 
cellular and molecular mechanisms that mediate these stages. 
1.1.1 Early Stages: Response to Injury 
I.A.1. Clot & Inflammation 
After a bone sustains a trauma that fractures a bone, the blood vessels in the 
highly vascular bone begin to leak blood into the injury site. This hematoma initiates 
the inflammatory response and simultaneously forms a fibrin clot within the 
medullary cavity of the bone; thus establishing an epicenter for signaling and a 
template for callus formation (Gerstenfeld, Cullinane, Barnes, Graves, & Einhorn, 
2003). This rapid inflammatory response peaks within the first 24 hours and is 
usually complete within a week (Lieberman & Friedlaender, 2005).  
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Figure 4 Characteristic ECM protein expressions during fracture healing 
At the top is an overview of the stages of fracture healing. The line plots show the level of gene 
expression for three different biomarkers that indicate different cell types that are present at the 
site of injury. These biomarkers can demarcate the phases of the healing process. Col2a is a 
biomarker for chondrocytes, OCN is a marker for osteoblasts, and IL-1beta is an interleukin 
present during the inflammatory response. Adapted from Hankenson et al., 2014 
Immune cells remove necrotic tissue, secrete cytokines, and kill any potential 
pathogens that could start an infection (Einhorn, 1998; Gerstenfeld, Cullinane, et al., 
2003).  
The inflammatory process is an important signaling stage in fracture healing. 
Macrophages, immune cells and even cells in the periosteum have been linked with 
secreting cytokines after initial reaction to injury. Tumor necrosis factor alpha 
(TNF-α), Interleukins-1 and -6 (IL-1 and IL-6) are three key cytokines that are 
important for initiating the healing process (E. Tsiridis & Giannoudis, 2006). 
Together these three cytokines have been shown to recruit MSCs and immune cells, 
promote vascular invasion, stimulate production of the extracellular matrix and 
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fibrotic components, and may also play an important in differentiating MSCs 
(Keramaris, Calori, Nikolaou, Schemitsch, & Giannoudis, 2008; S. K. Lee & Lorenzo, 
2006; Lehmann et al., 2005). These cytokines are also involved with other parts of 
the fracture healing process; particularly TNF-α has been linked with inducing 
apoptosis of hypertrophic chondrocytes during endochondral ossification, and 
stimulation osteoclastic function (Lehmann et al., 2005). These three cytokines have 
also been observed to have increased levels of expression towards the end of 
fracture healing when the bone is undergoing remodeling and forming secondary 
(lamellar) bone. (Cho et al., 2006; Gerstenfeld, Cho, et al., 2003; Kon et al., 2001; E. 
Tsiridis & Giannoudis, 2006; Eleftherios Tsiridis, Upadhyay, & Giannoudis, 2007). 
Li et al. utilized a fractured rat femur as an animal model to characterize gene 
expression the first four days of fracture healing. The group characterized 
inflammation into four sub-processes (Figure 5). Group A: Genes that immediately 
respond to injury. These genes were biologically related to transport activities (e.g. 
cytochrome-c-oxidase, Calcium channel α1s subunit), energy production (e.g. 
enolase, sarcomeric mitochondrial creatine kinase, phosphofructokinase, lactate 
dehydrogenase, aldolase A), catalytic activities (e.g. protein phosphatase, and serine  
proteinase inhibitors), and binding activity (mostly ATP binding genes)(Li, Quigg, 
Zhou, Ryaby, & Wang, 2005).  The group hypothesized that the large concentration 
of genes related energy production, transport, and binding activities are important 
mechanisms to initiate the healing process and to signal to the surrounding tissue 
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about the trauma. Moreover, Li et al highlighted that expression of these site 
preparation genes is fairly short-lived (Figure 5), speculating that this helps to 
minimize the high energy demand (Li et al., 2005). 
Group B: Genes that built expression over four days. The functional analysis 
conducted by Li et al indicated that over 60% of these genes were related to 
development of  cytoskeleton, ECM, and mediating growth factors (Li et al., 2005). 
The group reported that these findings were in line with Hadjiargyrou and Rubin et 
al., 2002, and both groups conjectured that these genes play a role in the 
overlapping processes of both chondrogenesis and osteogenesis (Li et al., 2005).  Li 
et al also highlighted that in contrast to Group A, group B had significantly less gene 
expression related to energy derivation and transporter activities (Li et al., 2005). 
Group C: Constantly upregulated genes and Group D: Constantly down 
regulated genes were very small clusters having 47 and 53 genes, respectively. Li et 
al concluded that there was not a dominant function within the heterogeneous 
Group C mixture. The group found that half of the genes in Group D were related the 
immune response, with a large subset related to immunoglobulin genes, but the 
group did not further characterize these expression profiles (Li et al., 2005). 
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Figure 5 Early Gene Expression Clusters 
Li et al. utilized hierarchical clustering to group mRNA expressions over three time points (D0, 
POD 1, D4) and day zero. The group found four temporally distinct clusters (A, B, C, D) Red 
indicates upregulation and blue represents down regulation. From Lie et. al, 2005. 
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I.A.2. Stem Cell Recruitment 
Some of the ligands secreted from the site of injury spatially coordinate the 
recruitment of stem cells to the fracture location. The exact molecules mediating 
recruitment, and the origin of the new MSCs are both topics of debate and research 
(Marsell & Einhorn, 2011). It has been eluted that  the stromal derived factor 1 
(SDF-1) and G-protein coupled receptor (CXCR-4) ligand/receptor pair is a 
cornerstone signaling axis to recruit specific MSCs to the fracture site (Granero-
Molto et al., 2009; Kitaori et al., 2009; Ma et al., 2005). This signaling pathway has 
demonstrated SDF-1 specifically targets CXCR-4 expressing MSCs, and has a positive 
correlation with the ability for a bone fracture to heal (Gerstenfeld et al., 2006; 
Kitaori et al., 2009).  The expression of SDF-1 is spatially regulated by the hypoxia 
inducible factor-1α (HIF-1α) transcription factor. HIF-1α is expressed under hypoxic 
conditions and, therefore, HIF-1α and SDF-1 expression levels follow the hypoxic 
gradient created by the fracture site, and give direction to the CXCR-4 expressing 
MSCs (Ceradini et al., 2004; Wan et al., 2008). In addition, bone morphogenic 
proteins (BMP-7 more so than BMP-2) have been linked to recruitment of MSCs 
(Bais et al., 2009).  There is some speculation about the origins of MSCs; current  
evidence suggests that progenitor cells from the endosteum contribute to the 
formation of bone, and progenitor cells  originating from the periosteum contribute 
to both cartilage and bone formation (Colnot, 2009; Hankenson et al., 2014; 
Rockwood, Green, & Bucholz, 2010).  
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1.1.2 MSC Differentiation & Chondrogenesis 
Chondrogenesis and ossification have significant overlap. Following the 
arrival of MSCs to the fracture site, there is a complex cascade of key growth and 
transcription factors that differentiate MSCs towards the appropriate cell linage, and 
simultaneously coordinate vascularization/ neoangiogenesis.  
There are hallmark biological markers associated with the presences of 
different cell types that demark the stages of the healing process.  One of the first 
sign of chondrocytes is the expression of Type II Collagen (col2a1) and Aggrecan 
(ACAN) (E. Tsiridis & Giannoudis, 2006). As the chondrocytes mature and 
hypertrophy, the expression of Type II Collagen transitions to Type X Collagen 
(col10a1) and the ECM proteins associated with osteoblasts begins to take over. 
Osteoblasts are also associated the expression of alkaline phosphatase (ALP), 
osteoprotegerin (OPG), and osterix (E. Tsiridis & Giannoudis, 2006).  
Many investigations have looked at various factors that influence stem cell 
differentiation (Wang et al 2014). Several factors that have been tied to stem cell 
differentiation and maturation during fracture healing are: TGF-β, BMPs, and PTHrP 
(Hankenson et al., 2014; E. Tsiridis & Giannoudis, 2006). One specific family of 
growth factors, bone morphogenic protein 2 (BMP2), has been the focus of a 
substantial amount of research because it is correlated with differentiating the stem 
cells that are recruited to the site of injury (E. Tsiridis & Giannoudis, 2006).  During 
the endochondral ossification period, it has been demonstrated that there is also an 
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increased expression of growth factors: TGF, GDF5, and MMP9 (E. Tsiridis & 
Giannoudis, 2006). Sox9, Sox5, Runx2, Osterix are important transcription factors 
for directing mesenchymal stem cells toward chondrogenic and osteogenic lineages 
(Vortkamp et al., 1998).  Some additional key factors are highlighted below in Figure 
6. 
 
 
Figure 6 Fates of osteochondroprogenitor cells 
Overview of the key regulators that differentiate osteochondroprogenitor cells towards osteoblasts 
or chondrocytes. Blue: transcription factors, Red asterisks: genes known to have human diseases 
associated with mutations, Green: Post-transcriptional modifiers. From Karsenty, 2008 
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1.1.3 Vascularization, Neoangiogenesis, Cartilage Resorption 
& Primary Bone Formation 
Angiogenesis (further growth of already established blood vessels) and 
vasculogenesis/neoangiogenesis (the creation of new blood vessels) bring oxygen, 
cells, and nutrients to the fracture site. It has been observed by Hankerson et al that 
oxygen levels drop dramatically in response to injury, but return to normal levels 
over the first few days of healing (Hankenson et al., 2014). Just as in endochondral 
bone formation, the invasion of blood vessels promotes the transform the avascular 
cartilage into vascular osseous tissue.  This angiogenesis process brings in 
monocyte-macrophages progenitor cells to the fracture site that will become 
osteoclasts to help resorb cartilage and allow for osteoblast to lay down primary 
bone (Standring, 2016). 
 The two main transcription and growth factors promoting angiogenesis are 
the angiopoietin pathway and the VEGF, respectively. Lehmann et al found that 
these two angiogenetic factors are regulated by TNF-α signaling in chondrocytes. 
Angiopoietin with VEGF seems to have a synergistic effect on vasculogenesis, and 
plays an important role in recruitment vascular in-growth of from blood vessels in 
the periosteum (Keramaris et al., 2008; Lehmann et al., 2005; Marsell & Einhorn, 
2011). It has been observed that systemically antagonizing the VEGF receptor, via a 
soluble immunoglobulin (Flt-(1-3)-IgG)), stops vascular invasion into the fracture 
site and impedes bone formation, and increasing VEGF increases vascular 
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development. These findings indicate that the VEGF plays an essential role in 
angiogenesis and vasculogenesis (Ai-Aql, Alagl, Graves, Gerstenfeld, & Einhorn, 
2008; Gerber et al., 1999; Marsell & Einhorn, 2011).  
1.1.4 Secondary Bone Formation & Bone Remodeling 
The resorption of primary bone in the callus and the formation of the original 
lamellar cortical and/or trabecular bone is the last phase of fracture repair and 
usually occurs around 3-4 weeks in mice (Marsell & Einhorn, 2011). Osteoclasts are 
the primary cell that resorbs bone and cartilage for remodeling. The expression of 
tartrate-resistant acid phosphatase indicate that a hematopoietic monocytes have 
undergone has differentiated into multinucleated osteoclasts (E. Tsiridis & 
Giannoudis, 2006). When osteoclasts adhere to bone they polarize and create a 
ruffled border that seals off a micro environment between them and the bone. The 
osteoclasts secrete acid, proteinases, and collagenases into this resorption bays, aka 
Howship’s lacunae, to break down the woven bone (Clarke, 2008). After the 
osteoclasts have resorbed the primary bone, osteoblasts follow to lay down new 
lamellar bone in its place.  
 
1.2 Interplay between glucose, bone formation and osteoblast differentiation 
A few key transcription factors, enzymes and molecules that are relevant to 
the interplay between glucose and bone formation will be briefly defined. Then we 
will look at the regulatory relationships between glucose, collagen production and 
osteoblast differentiation. 
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 Runx2 is the master transcription factor regulator of osteoblast 
differentiation, and also plays a role in chondrocyte differentiation (Figure 6) 
(Karsenty, Kronenberg, & Settembre, 2009; Long, 2012). AMPK is a kinase activated, 
among other stimulus, by low energy sates and has influence over many processes 
including glucose metabolism, lipid metabolism, and cell growth (Mihaylova & 
Shaw, 2011). Type I collagen is the most abundant ECM protein found in bone and is 
a common biomarker for presence of osteoblasts and osteogenesis. Osteoblasts 
secrete an endocrine hormone called osteocalcin that has two main forms: γ-
carboxylated and γ-decarboxylated form. The γ-carboxylated is an ECM protein has 
been linked with determining the size and shape of hydroxyapatite in bone (N. K. 
Lee et al., 2007). On the other hand, Lee et al. found that the γ-decarboxylated form 
works as an endocrine hormone and increases β-cell proliferation, insulin secretion, 
and increase insulin sensitivity in peripheral tissues; leading to the conclusion that 
osteocalcin is important for maintaining glucose homeostasis (N. K. Lee et al., 2007). 
In vivo, it has been observed that Type I collagen is present before 
expression of Runx2 is upregulated, and this is puzzling because, in vitro, Runx2 can 
initiate the production of Type I collage (Wei et al., 2015). Last year, Wei et al. found 
a relationship in osteoblasts between glucose, AMPK, bone development and cell 
differentiation. The group illustrated this relationship in Figure 7 (Wei et al., 2015). 
First the group found that osteoblast had insulin independent preference glucose 
compared to any other nutrient. The uptake of glucose through Glut1 channels had 
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two large downstream affects: Path A inhibits mTOC1 and promotes formation of 
Type I Collage (Col1a1), the primary component of bone (Figure 7).  
 
Figure 7 Regulation of osteoblasts via glucose 
This carton illustrates the two processes directly affected by glucose: (A) bone formation and (B) 
Runx2 degradation. Downstream, Runx2 promotes three processes important to fracture healing 
(B1) Glut1 expression, (B2) Osteocalcin expression, and (B3) osteoblast differentiation. Adapted 
from Wei et al. 2015 
Path B inhibits of the ubiquitination of Runx2 (Figure 7). The promotion of 
Runx2 expression has three downstream effects: (1) there is a feedforward 
upregulation for more Glut1 receptors, (2) the upregulation of osteocalcin (Ocn), 
and (3) promotes osteoblast differentiation. The group conjectures that in 
osteoblasts, glucose uptake is necessary for whole body glucose homeostasis via 
osteocalcin and necessary for formation because it directly promotes production of 
Col1a1. They further propose that Runx2 requires presence of glucose to promote 
osteoblast differentiation. It is interesting that the group noted that Ruxn2 is 
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necessary for osteoblast differentiation and mineralization (via upregulation of 
Akp2), but that the expression of other components of the bone ECM proteins is 
regulated by other mechanisms (Wei et al., 2015). 
1.3 Phosphate Restriction and Energy Metabolism 
There is a long standing relationship between low serum inorganic 
phosphate (Pi) and decreased ATP levels. In 1938,  Rappaport and Guest reported 
that rats on a rachitic diet a had low ATP concentrations in red blood cells (RBCs) 
(Travis  et al., 1971). In 1969, Freeman RB et al. made the same observations in 
patients receiving hyperalimentation (Travis  et al., 1971). In 1971, 
Frank A. Oski, M.D. et al systematically investigated these observations in 
hypophosphatemic patients and found increased concentrations of Glyceraldehyde 
3-phosphate  of triose phosphates that occurs in vivo secondary to 
hypophosphatemia appears to be a direct result of insufficient inorganic phosphate, 
a cofactor at the glyceraldehyde-3-phosphate dehydrogenase step (Travis et al., 
1971). 
Zelenchuk et al identified three key regulatory pathways that link energy 
metabolism and bone-kidney mineral metabolism: (1) Bone formation and 
resorption regulate blood glucose via a feedback control loop by insulin and 
osteocalcin.  (2) Adipose secreted leptin can enter the CNS to affect the level of 
serotonin synapsing on to osteoblastic via B-adrenergic receptors and promote the 
formation of bone. (3) Gut derived serotonin, on the other hand, interacts with Low-
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density lipoprotein receptor-related protein 5 (Lrp5) and promotes bone resorption 
(Zelenchuk, Hedge, & Rowe, 2014). In 2006, Happ et a. investigated the role of 
phosphate in healthy individuals. The group found that serum phosphate levels 
were negatively correlated with 2-h blood glucose levels and a positively correlated 
with insulin sensitivity (Haap et al., 2006; Paula, Plens, & Foss, 1998). In 2014, 
Zelenchuk et al observed that x-linked hypophosphatemic mice (HYP) mice are 
hyperglycemic, hyopinsulinemic and hypouricemic (uric acid) and have reduced 
leptin and adiponectin levels. Zelenchuck et al. proposes that inducing 
hypophosphatemia compromises utilization of glucose, increases resistance insulin, 
and results in hyperinsulinemia (Zelenchuk et al., 2014). Van de Werve, G.’s group 
published three papers that both push the ideal that x-linked hypophosphatemic 
rats and rats fed a phosphate deficient diets (Pi) upregulate the expression of the 
enzyme glucose-6-phosphatase in the liver that leads to glucose intolerance and 
hyperglycemia (Xie, Li, Méchin, & Van De Werve, 1999; Xie, Méchin, Dubois, 
Lajeunesse, & van de Werve, 2002; Xie, Tran, Finegood, & van de Werve, 2000). 
A  phosphate restrictive diet has also been shown to impair healing of fractures and 
resistance to bone morphogenic protein 2 (BMP-2) (Wigner et al., 2010). 
1.4 Microarray and Time Series 
An approach that is becoming more prevalent is to use microarrays to look at 
the progression of a given biological process over a given time series – this is the 
approach our group did relating to the fracture healing study (Bar-Joseph, Gitter, & 
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Simon, 2012).. This approach offers better insight into the changes that are 
occurring at the molecular level rather than a single snapshot. A key assumption 
that presents with looking a time series, is that taking a snapshot at a given point 
time will yield the same composition in a repeatable manner. To make this 
assumption true, synchronizing cells to a progressive process is key and important 
to understanding an underlying mechanism (Bar-Joseph et al., 2012). Thus, fracture 
healing is a good model because the repair of a bone has a defined beginning that 
will coordinate the cells in the surrounding bone towards a singular process. 
Looking at microarray over time also adds new confounding issues like the large 
number of samples that need to be collected and normalizing these samples across 
batch effects and repeatability during the experiment.  
1.4.1 Representing Gene Temporal Profiles 
 Gene expression taking place over a time series can be presented in multiple 
graphics. A common representation is through a heat map (Figure 5) that represents 
up or down regulation by the color and the magnitude is represented by the 
intensity of the given color. Heat maps are limited because they cannot easily 
demonstrate uneven time intervals  (Bar-Joseph et al., 2012). Our group chose to 
plot the gene expression profiles using a custom Matlab script that produced 
piecewise linear curves – plots that connect expression levels at each time with 
straight lines. This is in contrast to trying to create a smooth polynomial function 
that is fitted to the temporal gene expression profile (Bar-Joseph et al., 2012).  
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1.4.2 Determining Differentially Expressed Genes 
Methods for deeming a gene as differentially expressed over time is highly 
variable. On the more simplistic side of the continuum, an ad-hoc definition is to 
define a threshold fold change that must occur at a given number of time points. For 
example, a gene is deemed differentially expressed if it has two times fold change at 
a minimum of three time points. Other groups employ statistical software that aims 
to identify differential expression through a combination of statistical approaches 
like analysis of covariance (ANOVA) (Bar-Joseph et al., 2012). 
1.5 Clustering & Analysis of gene expression 
There are two predominate approaches to analyzing large datasets: 
supervised learning and unsupervised learning. Supervised learning leverages 
known inputs and annotated outputs to make reasonable predictions about newly 
presented data. An example of supervised learning is identifying patients with a 
higher risk of developing certain cancers based on their gene-expression profile 
(Shipp et al., 2002).  The transcriptomic data that has been annotated with past 
patient diagnoses helps to classify new gene expression profiles and determine if a 
given patient is at higher risk of certain cancers. On the other hand, unsupervised 
learning tries to surmise conclusions based on a dataset that with no a prior 
knowledge of patterns that may be presented in the data (Grant, 2004). Common 
applications for unsupervised learning are creating categorical bins for similar 
online news stories for a given day or any clustering method. 
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1.5.1 Normal (Gaussian) Mixtures Clustering & Expectation-Maximization (EM)  
Clustering time-series clustering data is difficult and the best approach is a 
topic of debate (Bar-Joseph et al., 2012; Zolhavarieh, Aghabozorgi, & Teh, 2014). 
Normal Mixtures is an unsupervised learning approach that uses multivariate 
Gaussian curves to cluster data into groups that are most similar. The final 
distribution of Gaussian curves can be determined via multiple avenues: Monte 
Carlo simulations method, numerical optimization via Newton's method, and by the 
expectation-maximization algorithm (Barber, 2011). The Normal Mixtures is a soft 
clustering algorithm provided by JMP that utilizes the iterative expectation-
maximization (EM) algorithm to optimize Gaussian curves’ parameters and their 
special distribution to best fit data nodes (SAS, 2015). 
The goal of the EM algorithm is to determine the parameters and distribution 
for multiple the Gaussian curves that best fits all the given data points and maximize 
the log likelihood function. Figure 8 outlines the overall EM algorithm – the first step 
of the EM algorithm is to randomly seed the data with Gaussians curves 
(Frame A)(Ihler, 2015). Then the algorithm begins a two-step iterative process. 
First, during the expectation step (E-step), the parameters governing the Gaussian 
curve are fixed and the membership for each node to each Gaussian curve is 
computed (Figure 8) (Ihler, 2015). This calculation allows for one node to be 
assigned to multiple Gaussian curves. Second, during the maximization step 
(M-step), the calculated memberships are used to optimize parameters that govern 
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the Gaussian curves to best describe the distribution of nodes under each Gaussian 
curve (Figure 8). This EM cycle continues as until a convergence criterion is met 
(Figure 8). Each iteration increases the log(likelihood) value, indicating a better fit 
of the Gaussian parameters and distributions in space to the given data. Although 
this metric is not absolute value of fit, it can be combined with a penalty term to 
compare models with different numbers of Gaussians. 
 
Figure 8 Estimation-Maximization (EM) Progression 
The illustration shows frame by frame EM progression using Gaussian mixtures clustering in two 
dimensions. (A) Initial seeding of clusters, (B) Estimation Step: assignment of nodes to nearest 
Gaussian, (C) Maximization Step: adjustment of Gaussians to best fit the assigned nodes. (D-E) 
Iterative EM steps are continued. (F) The Gaussians distributions have settled and reached the 
convergence criterion. Adapted from Project Rhea at Perdue University. 
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1.5.2 Cluster number and Information Criterion 
One common obstacle that must be evaluated when using flat clustering 
methods like normal mixtures, is that the user must first determine a number 
clusters to group the given dataset. There are several metrics that try to quantity the 
quality of a given model. Two common metrics are the Akaike information criterion 
(AIC) and the Bayesian information criterion (BIC). These two criterions to balance 
the "goodness of fit" of the likelihood function and the complexity of the model 
(Chris Fraley & Adrian E. Raftery, 1998). These criterion are not absolute values, 
and therefore cannot be used to compare model quality across different clustering 
methods nor even between AIC an BIC. For both criterions, a more negative value 
represents a better fit. BIC more heavily penalizes for increased complexity in the 
model and therefore tends to under cluster compared to the AIC value (Chris Fraley 
& Adrian E. Raftery, 1998). Using both in conjunction provides a range of optimal 
clusters to test which metric provides better resolution. 
𝐴𝐼𝐶 =  −2𝑘 − 2 ln(?̂?) 
𝐵𝐼𝐶 =  −2 ∙ ln ?̂? + 𝑘 ∙ ln(𝑛) 
?̂? = 𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑 𝑓𝑢𝑛𝑐𝑡𝑖𝑜𝑛 (𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 𝑥𝑥) 
𝑘 = # 𝑜𝑓 𝑐𝑙𝑢𝑠𝑡𝑒𝑟𝑠 𝑖𝑛 𝑡ℎ𝑒 𝑚𝑜𝑑𝑒𝑙 
𝑛 = # 𝑜𝑓 𝑑𝑎𝑡𝑎 𝑝𝑜𝑖𝑛𝑡𝑠 𝑖𝑛 𝑚𝑜𝑑𝑒𝑙 
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1.5.3 Reasons for Model Section 
Normal Mixtures method can be applied to an infinite number of dimensions. 
With time series data, each time point was utilized as a new dimension, hence each 
gene’s temporal expression profile can be characterized by a nine dimensional 
vector. By clustering the gene profiles in nine dimensions, the space that a set of 
genes occupy together indicates that said genes moved in the same manner for the 
majority of the time points. Moreover, the normal mixture approach tries to model 
data by distributions rather than finite distances (Ihler, 2015). This offers 
advantages to hierarchical or k-means clustering that commonly evaluate similarity 
using Euclidian distance to determine similarity. This is especially important when 
nodes are closely grouped together and causes clusters to have overlap. Hierarchical 
and k-means clustering assign definitive memberships based on the distance 
between the cluster centroid and the position of the node in space. However, using 
normal mixtures the shape of the Gaussian curve can adjust along the axis of 
variance (because each node can have multiple memberships), and are more likely 
to capture these trends when nodes are closely associated in space (Ihler, 2015). 
1.6 Study Aims 
This project investigates how genetic factors interact with various 
environmental factors to affect fracture healing.  In this study three inbred strains of 
mice: A/J (AJ), C57BL/6J (B6), and C3H/HeJ (C3) were used to model genetic 
variability.  The environment of healing was altered by feeding the experimental 
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group of mice a low phosphate diet to produce a hypophosphatemic/rachitic state.   
It was originally observed by Jepsen et al that these three strains have inherent 
genetic variation in the temporal regulation of fracture healing that leads to 
differences in the geometry of callus formation, composition and mechanical 
properties (Jepsen et al., 2008). The phosphate deficiency has also shown strain 
dependent temporal shifts in stages of fracture healing, and differences in regain of 
mechanical strength (Hogue, 2014). mRNA was also collected at nine time points  
during this study and an initial ANCOVA was performed to look at genes that were 
significantly affected by the diet perturbation (q-value ≤ 0.005 (3052 genes)). These 
gene were analyzed for significant biological functions and it was found metabolic-
related functions oxidative phosphorylation and mitochondrial dysfunction were 
among the top pathways that were affected by the phosphate deficiency (Hussein, 
2015).  
The goals of this study were to expand on this initial assessment to (1) 
characterize the temporal profiles of oxidative phosphorylation, (2) determine if 
phosphate deficiency more broadly altered intermediate metabolism during 
fracture healing, and (3) investigate any genetic variation that occurs within these 
processes. 
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2 METHODS  
2.1 Experimental Design 
All animal studies were conducted under an approved Institutional Animal 
Care and Use Committee (IACUC) protocol at Boston University School of Medicine.  
Three strains of inbreed mice A/J (AJ), C57BL/6J (B6), and C3H/HeJ (C3) of male 
mice were procured from Jackson Labs. These mice were 8- to 12-weeks old when 
they had stabilized fractures made in the right femur as preciously detailed by 
(Bonnarens & Einhorn, 1984) using the modifications as described for mice (Jepsen 
et al., 2008).  The control group (Crtl) was fed standard mouse chow diet (Harlan 
Laboratories, Madison, WI) diet throughout the study. The experimental group (Pi) 
was fed a low phosphate diet as previously described in (Wigner et al.  2010) and 
prepared by  (Harlan Laboratories, Madison, WI) starting two days before fracture 
and continued for 16 days after which, the normal diet was re-introduced.  
 
Figure 9 Experimental set up 
(A) X-ray of stable femur fracture in the right femur of a mouse utilizing the Einhorn technique 
(B) This cartoon illustrates the timeline for phosphate restricted diet (in blue) for the experimental 
group of mice compared to the control groups. RNA was collected at each time point for all three 
strains of mice. Adapted from Hussein, 2015 
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Six fracture calluses were harvested for each experimental group 
(diet*strain*time point), specifically at post-operative days (POD): 3, 5, 7, 10, 14, 18, 
21, 28, and 35 days (Figure 9). Additionally, 3 samples per strain were collected at 
day zero for controls. RNA was extracted from the callus of the harvested right 
femur (Matheny, 20014). The RNA from two mice were pooled together to help 
minimize variance between samples, yielding 3 RNA samples per experimental 
group. Given the limit on the number of samples that can be measured in one array 
(max 48 samples/batch), 17 samples were replicated within each batch to account 
for batch effects.  
3 𝑠𝑎𝑚𝑝𝑙𝑒𝑠
𝑡𝑖𝑚𝑒 𝑝𝑜𝑖𝑛𝑡 ∙ 𝑠𝑡𝑟𝑎𝑖𝑛
× 9 𝑡𝑖𝑚𝑒𝑝𝑜𝑖𝑛𝑡𝑠 𝑥 3 𝑠𝑡𝑟𝑎𝑖𝑛𝑠 = 162 𝑠𝑎𝑚𝑝𝑙𝑒𝑠 
3 Ctrl D0
𝑠𝑡𝑟𝑎𝑖𝑛
× 3 𝑠𝑡𝑟𝑎𝑖𝑛𝑠 = 9 𝑠𝑎𝑚𝑝𝑙𝑒𝑠 
17 𝑠𝑎𝑚𝑝𝑙𝑒𝑠
𝑏𝑎𝑡𝑐ℎ
× 4 𝑎𝑑𝑑𝑖𝑡𝑖𝑜𝑛𝑎𝑙 𝑏𝑎𝑡𝑐ℎ𝑒𝑠 = 68 𝑠𝑎𝑚𝑝𝑙𝑒𝑠 
239 total samples 
2.2 Microarray 
The Affymetrix Mouse Gene 1.0 ST chip was used for this study.  The Boston 
University Clinical and Translational Science Institute (BU CTSI) Bioinformatics 
Group completed the raw-data pre-processing, normalization and initial differential 
gene expression analysis. The baseline raw gene-level expression values were 
determined using the Robust Multiarray Average (RMA) (Version 1.36.1) (Gautier, 
Cope, Bolstad, & Irizarry, 2004). The Chip Definition File (CDF) program was then 
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employed to match the unique probe cDNA sequences on the microarray chips to 
unique Entrez Gene Identifiers (Entrez Gene IDs). Quality control (QC) was assessed 
using the Relative Log Expression (RLE) and Normalized Unscaled Standard Error 
(NUSE). After the quality control, ComBat algorithm (SVA Package version 3.4.0) 
was used to correct for batch effects across the five batches. 
2.3 Statistical Analysis & Data Selection 
The absolute, batch-corrected values of expression of 21,187 genes from the 
microarray data were utilized in this study.  Analysis of covariance (ANCOVA), using 
time and strain as covariates, identified the genes that were significantly affected by 
the hypophosphatemic diet (SAS 9.4, Inc., Cary, NC).  A false discovery rate q-value 
(FDR q-value< 0.05) was used to select a subset of genes that were significantly 
affected by the phosphate deficiency.  This yielded 7,188 “diet significant genes” that 
had statistically different gene expression between the control and phosphate 
deficient experimental group. The Kyoto Encyclopedia of Genes and Genomes 
(KEGG) was used as the reference database to curate a comprehensive list of genes 
that were related to intermediate metabolism and energy production under five 
main branches of intermediate metabolism: amino acid metabolism, carbohydrate 
metabolism, energy metabolism (oxidative phosphorylation), lipid metabolism.  We 
further selected three signaling pathways (PI3k-Akt, AMPK and mTOR) that have 
been associated with regulation of metabolic functions to further investigate in the 
context of hypophosphatemia.  To account for genes with multiple functions being 
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assigned to more than one of the category, each gene was assigned a weighted 
average to each of the categories under which it participated.  For example, if a gene 
participated in both carbohydrate metabolism and the AMPK signaling cascade, then 
the gene would be calculated to have a 0.5 association with both categories. 
 This comprehensive list of associated genes for intermediate metabolism 
genes was then compared against the 7,188 diet significant genes, and the 
intersection of these two sets was 577 “diet significant metabolism genes”.  These 
genes slightly favored signaling transduction that comprises 24.18%, followed by 
carbohydrate metabolism 19.84%. The remaining categories were relatively equally 
represented oxidative phosphorylation (16.55%), amino acid metabolism (14.21%), 
nucleotide metabolism (13.60%) and lipid metabolism (11.62%).  Figure 11 
summarizes the flow chart of the gene selection protocol that was then used for our 
subsequent analysis. 
 
Figure 10 Flow chart illustrating gene selection for clustering analysis. 
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2.4 Cluster Techniques 
Clustering was employed to group genes that had similar temporal 
expression profiles during fracture healing. Genes that have similar temporal 
profiles generally regulate a similar function or are mediated by a common 
upstream regulator. Expanding this principle between the control and experimental 
group, genes that have similar profiles in both the control and experimental group 
are inferred to be effected in the same manner by the phosphate deficient 
perturbation. Expanding this concept across multiple strains helps to elute strain 
invariant mechanisms that are affected by phosphate deficiency.  
Multiple clustering approaches were attempted to capture these attributes. 
GPTwoSample was a Bayesian clustering technique that utilizes Gaussian process 
regression to detect time intervals where genes are differentially expressed. Several 
attempts were made at clustering the full data set of differentially expressed genes 
identified by ANCOVA (at FRD q-value < 0.005 n = 3,111, and 
FDR q-value < 0.05 n = 7,188), as well as the subset of these genes related to 
metabolism. This approached scored genes that were differentially expressed over 
time, temporally shifted, and attempted to cluster together sets of genes that had 
similar profiles. Unfortunately, the clusters that were produced did not have distinct 
temporal profiles. Moreover, the genes that were identified to be most differently 
expressed or temporally shifted had incongruent profiles and therefore did not 
accurately capture genes that regulate similar processes. 
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After investigating k-means and hierarchical clustering, normal mixtures was 
selected for the next approach because of the advantages offered by soft clustering. 
First, the Ctrl and Pi expression groups were clustered individually. Genes were 
tracked together first between the Pi group and Ctrl group, and then across multiple 
strains. This approach lead to an exponential number of combinations that was very 
difficult to extrapolate any meaningful information. However the expression profiles 
in each cluster did show more congruencies.  Therefore, looking at the ratio of the 
phosphate deficient (Pi) and control (Ctrl) expression was a logical step to allow us 
to compare changes that were similar through time and reduce the number of 
combinations that needed to be compared. 
The absolute gene expression for experimental phosphate deficient group 
(Pi) was divided by the control group (Ctrl) for each strain, for each gene, at each 
time point. These ratios were utilized to capture genes that had similar changes in 
patterns in gene expression in the control group compared to the phosphate 
deficient group. 
𝑃𝑖/𝐶𝑡𝑟𝑙(𝑘,𝑠,𝑡) =
𝑃𝑖(𝑠,𝑘,𝑡)
𝐶𝑡𝑟𝑙(𝑠,𝑘,𝑡)
 
 
𝑃𝑖 = 𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙 𝑔𝑟𝑜𝑢𝑝 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 
𝐶𝑡𝑟𝑙 = 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑔𝑟𝑜𝑢𝑝 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 
 
𝑃𝑖
𝐶𝑡𝑟𝑙
= 𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑟𝑎𝑡𝑖𝑜 𝑜𝑓 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 
 
𝑡 = 𝑡𝑖𝑚𝑒 𝑝𝑜𝑖𝑛𝑡 
𝑘 = 𝑔𝑒𝑛𝑒 
𝑠 = 𝑠𝑡𝑟𝑎𝑖𝑛 
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For each strain, normal mixtures approach was used to cluster the genes 
together that had similar temporal ratio of expression (Pi/Ctrl) (JMP Pro version 
12.1.0 by SAS Inc., Cary, NC). The following settings were applied: the ratios were 
not normalized, the clustering had a convergence criterion of 1x10-8, the number of 
independent restarts was increased from 30 to 100 to protect against finding a local 
solution, and the EM algorithm was allowed a maximum of 1,000 iterations to reach 
the convergence criterion. To determine the optimal number of clusters that each 
strain should be clustered into, the genes were iteratively clustered from 2 - 25 
clustered. For all three strains, the clustering results were qualitatively evaluated 
from the Bayesian information criterion (BIC) minimum to the Akaike information 
criterion (AIC) minimum to determine which metric yielded better resolution. 
Resolution was defined as: with each step in cluster number, the new child cluster 
provided a distinctly different pattern than the parent. 
2.5 Gene Tracking via Relational Matrices 
2.5.1 Across all three strains 
Based on the optimization and grouping of the normal mixtures, each gene is 
assigned to a given cluster (1,2,3..k). These clustering assignments were then 
utilized to create relational matrices for all three strains. All three of these relational 
matrices were summed to determine the genes that were clustered together in all 
three strains. Genes that were clustered together in multiple strains (i.e. the genes 
were clustered together in AJ, B6 and C3) were called a “set”. All sets that had 10 or 
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more genes were evaluated for significant biological function using KEGG pathways 
(via DAVID). A significant biological function was deemed by having a Fischer Exact 
p-value < 1x10-3. All genes that were part of a set with greater than 10 genes and 
were comprised a significant biological function were considered to “track across all 
strains”. 
2.5.2 Pairwise comparisons 
The genes that “tracked across all strains” were then removed from the total 
pool of genes for subsequent pairwise comparisons. All three pairwise combinations 
of the strains were evaluated: AJ/B6, AJ/C3 and B6/C3 to determine similarities and 
differences in metabolism between the strains.  All sets that were eluted from these 
comparisons were cataloged.  Following the same criteria for sets across all three 
strains, all genes that were in sets greater than 10 genes, and comprised a 
significant biological function were considered to “track between two given strains” 
(e.g. “track between AJ/B6”). 
2.6 Data Transformations for Plotting 
Two different plots were produced from the genes that had biological 
significance to look at the functions in different comparative lights. (1) The Pi/Ctrl 
ratio that showed how the genes expression change in the phosphate deficient 
group relative to the control group. (2) The mean of the standard scores for both the 
Pi and Ctrl groups. The standard score for a given gene was calculated based on the 
mean and standard deviation of expression across both the Ctrl and Pi group. Then 
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these standard scores were averaged to one value. This normalizes the vertical 
translation between various genes and allows one to focus on the increases and 
decreases in gene expression at each point in time.  
Standard Score:  
𝑥(𝑘,𝑡,𝑠) =  
𝑥(𝑘,𝑡,𝑠) − (
1
2𝑡
) (∑ 𝐶𝑡𝑟𝑙𝑘,𝑡,𝑠𝑡 + ∑ 𝑃𝑖𝑘,𝑡,𝑠𝑡 )
𝜎(𝐶𝑡𝑟𝑙𝑘,𝑡,𝑠 + 𝑃𝑖𝑘,𝑡,𝑠)
 
𝐶𝑡𝑟𝑙 = 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑔𝑟𝑜𝑢𝑝 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 
𝑃𝑖 = 𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙 𝑔𝑟𝑜𝑢𝑝 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 
𝑡 = 𝑡𝑖𝑚𝑒 𝑝𝑜𝑖𝑛𝑡 
𝑘 = 𝑔𝑒𝑛𝑒 
 
Figure 11 Plotting Transformations Exam 
(A) Pi/Ctrl ratio plotted for the two example genes, this ratio was used to capture genes that were 
similarly expressed over time. (B) The raw expression profiles for the two genes, note the vertical 
translation between the two gene’s baseline expressions. (C) Standard score transformation 
normalizes genes expressions to a uniform scale while maintaining changes that occur in time. 
(D) The mean of the standard scores are displayed to provide clarity between the Pi and Ctrl 
expression. 
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3 RESULTS 
3.1 Optimal Clusters & Gene Tracking 
Evaluation of the clustering results for all three strains from BIC minimum to 
AIC determined that the AIC had a better resolution than the BIC, and the AIC value 
was used to determine the optimal number of clusters. Figure 12 exemplifies this for 
the AJ strain. The AIC minimum determined that the optimal number of clusters for 
AJ, B6, and C3 were 6, 8, and 7 clusters, respectively (Figure 12). A group of genes 
that were clustered together in two or more strains were called a ‘set’ and will be 
identified by the notation “[5,1,5]” – indicating that the genes were found in AJ 
Cluster 5, B6 Cluster 1, and C3 Cluster 5. Pairwise sets will be denoted “[5,1,x]” – 
indicating that genes clustered together in AJ Cluster 5 and B6 Cluster 1, but not 
together in the C3 strain. 
Of the genes that showed statistical difference in expression based on the Pi 
treatment and which were associated with a significant metabolic function, 102 
unique genes tracked together amongst all the pairwise comparisons while 74 genes 
clustered together across all strains.  Within each pairwise comparison, 63, 72, and 
54 of these genes had significant biological functions in the AJ/B6, AJ/C3, and 
B6/C3, respectively.  The compositional break down of all these genes based upon 
their associated biological function within metabolism is shown in Figure 13 and the 
percentage of the total biological function is presented in  
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Table 1. Table 2 illustrates which strains were most similar based on the 
genes that tracked in a pairwise manner. 
 
Figure 12 Optimal Cluster Number 
(A) Example of AJ qualitative analysis where the parent cluster splits into two children with 
better resolution. (B –D) AIC and BIC plots for AJ, B6, and C3, respectively. Yellow and orange 
dots highlight the BIC and AIC minimums, respectively.  
 
Figure 13 Biological Composition of Genes that tracked amongst strains 
This figure shows the number of genes that tracked in each comparison, highlighting their 
biological function. 
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Table 1 Total Gene Tracking Results 
Break down of how all the genes tracked. The Across All Strains genes were separately identified 
to have similar profiles in all three strains and met the criteria for representing a significant 
biological function. The Pairwise group describes genes were identified separately in at least two 
strains and represented a significant biological function. The Did Not Track groups were genes 
that did not meet the criteria to be deemed a significant biological function. 
 
All 
(n = 74) 
Pairwise 
(n = 102) 
Did Not 
Track 
(n = 401) 
Energy Metabolism 
(n = 95.5) 
17.28% 
(n = 16.5) 
50.09% 
(n = 47.83) 
32.63% 
(n = 31.17) 
Amino Acid 
(n = 82) 
8.33% 
(n = 6.83) 
18.29% 
(n = 15) 
73.37% 
(n = 60.17) 
Carbohydrate 
(n = 114.5) 
11.64% 
(n = 13.33) 
16.16% 
(n = 18.50) 
72.20% 
(n = 82.67) 
Lipid 
(n = 67) 
0.50% 
(n  = 0.33) 
12.94% 
(n = 8.67) 
86.57% 
(n = 58.00) 
Nucleotide 
(n = 78.5) 
29.94% 
(n = 23.50) 
14.65% 
(n = 11.50) 
55.41% 
(n = 43.50) 
Signaling 
(n = 139.5) 
13.50% 
(n = 13.5) 
0.35% 
(n = 0.50) 
89.96% 
(125.50) 
 
Table 2 Pairwise Gene Tracking Results 
This table describes which pairwise comparisons captured the most similarities by biological 
function; the most similarity was between AJ and C3 strains. 
 AJ/B6 
10.92% 
(n = 63) 
AJ/C3 
12.48% 
(n = 72) 
B6/C3 
9.36% 
(n = 54) 
Energy Metabolism 
(n = 95.5) 
37.52% 
(n = 35.83) 
46.60% 
(n = 44.50) 
34.03% 
(n = 32.50) 
Amino Acid 
(n = 82) 
13.21% 
(n = 10.83) 
9.35% 
(n = 7.67) 
11.79% 
(n = 9.67) 
Carbohydrate 
(n = 114.5) 
6.40% 
(n = 7.33) 
8.01% 
(n = 9.17) 
4.51% 
(n = 5.17) 
Lipid 
(n = 67) 
2.99% 
(n = 2.00) 
1.00% 
(n = 0.67) 
9.95% 
(n = 6.67) 
Nucleotide 
(n = 78.5) 
8.28% 
(n = 6.50) 
12.74% 
(n = 10.00) 
0.00% 
(n = 0.00) 
Signaling 
(n = 139.5) 
0.36% 
(n = 0.50) 
0.00% 
(n = 0.00) 
0.00% 
(n = 0.00) 
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3.2 Oxidative Phosphorylation 
The primary function that tracked throughout all three of these comparisons 
was oxidative phosphorylation having ~68% (65 out of 96) of all the oxidative 
phosphorylation genes in the original data set tracked in some manner.  More 
precisely, 17 genes tracked across all three strains while the remainder of these 
genes tracked in pairwise comparisons between each of the strains.  It is also 
important to note that 17 of the genes found in the pairwise comparisons originally 
appeared in all three strains comparisons. However, they were not deemed 
significant under the “All Strain” heading because they tracked in sets smaller than 
10 genes. Figure 15 summarizes the subunits in the electron transport chain that 
were identified to be grouped together in the three strains. Each color comprised a 
different comparison and will be explored individually in the following sections. As a 
note, KEGG categorizes pyruvate dehydrogenase and tricarboxylic acid cycle (TCA) 
together. KEGG also categorizes TCA under the larger heading of carbohydrate 
metabolism, the teal color (3rd bar color) in Figure 13.  These genes will be 
investigated with oxidative phosphorylation because the succinate dehydrogenase 
complex overlaps with both processes and because these genes were identified in 
the same set as the oxidative phosphorylation genes. Figure 16 highlights the 
enzymes in pyruvate dehydrogenase and TCA that were identified to be grouped 
together in all three strains. 
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Figure 14 Electron Transport Chain Across All Strains 
The perimeter colors highlight the comparison that identified the genes to be group together. Black highlights genes that tracked together 
across all strains and grey highlights genes showed up in all three pairwise comparisons. The green fill colors represent the time averaged 
expression of a given gene. All of the genes identified above were down regulated in all of the strains. White filled components did not 
track across at all. 
Adapted from IPA, 2016.
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Figure 15 Electron Transport Chain Pairwise Comparisons 
This diagram illustrates the genes that tracked only in the pairwise comparisons. The perimeter colors identify the specific pairwise comparison 
that the gene was identified under. The green fill colors represent the time averaged expression of a given gene. All of the genes identified above 
were down regulated in all of the strains. Adapted from IPA, 2016. 
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Figure 16 Pyruvate Dehydrogenase, TCA and Prolyl 4 hydroxylase 
This figure illustrates the relationship collage production via prolyl 4 hydroxylase (P4H), its 
substrates that are products in the TCA cycle, and a few branches of intermediate metabolism that 
feed into the TCA to produce 2-oxogluterate (α-ketoglutarate): pyruvate and amino acids 
Arginine and Proline. Adapted from IPA 2016, Ferrier 2014, and McNeil, 2002. 
  
 43 
3.2.1 Across All Strains 
Two sets related to oxidative phosphorylation tracked across all strains. The 
genes that comprised set [5,1,5] were primarily related to the tricarboxylic acid 
cycle (TCA), Complex II (Succinate Dehydrogenase) of ETC, and the F1 subunit of 
ATP Synthase. Some notable enzymes that were identified include: pyruvate 
dehydrogenase, succinate dehydrogenase, 2-oxoglutarate dehydrogenase 
(α-ketoglutarate), and isocitrate dehydrogenase (Figure 16). Set [5,1,5] contained 
genes primarily related to Complex I  (NADH Ubiquinone Reductase). The temporal 
gene expression profiles for these sets are highlighted in Figure 17. 
While each strain had a different temporal expression profile, there were 
some similarities between the AJ and C3 strains (Figure 17). In both set [5,1,5] and 
[5,1,3] (Figure 17), AJ Pi/Ctrl relative expression peaked at day 7, whereas the C3 
strain peaked later at POD 10. Both AJ and C3 subsequently dropped to a low point 
at POD 14. Similar to C3 strain, B6 strain had a peak at POD 10, and also 
demonstrated the common valley at POD 14. However, unlike the AJ and C3 strain 
that have the Pi expression exceed the Ctrl expression, the B6 Pi/Ctrl ratio was 
attenuated and the Pi group only matches the control expression group at POD 10.  
Across all three strain expression profiles, it is interesting to see that the Pi/Ctrl 
ratio climbs from POD 14 to POD 18, coinciding with time period when the 
experimental group have phosphate reintroduced to the diet. After this rise, the AJ 
strain and C3 Pi/Ctrl ratios have a subsequent drop at POD 21, but the B6 strain has 
a different end behavior and the expression ratio plateaus around 1. 
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Set [5,1,5] standard score plots (Figure 17), show similar trends for AJ strain 
and C3. Overall, both the Ctrl and Pi gene expressions decrease from POD 3 to POD 
35 and the Pi profile is phase shifted compared to the Ctrl. The Ctrl group in both 
strains shows a decrease till POD 10 and then an increase that peaks at POD 14.  The 
Pi expression in both strains start above the average expression and fall around POD 
10 and POD 7, in AJ strain and C3 respectively. Then the AJ strain and C3 Pi group 
peak after the Ctrl at POD 18. The AJ strain and C3 profiles in [5,5,3] exemplify a 
very similar delay. The B6 strain Pi standard plot in both [5,1,5] and [5,5,3] never 
exceeds the mean expression of the gene and rarely exceeds the Ctrl expression. The 
In set [5,1,5], the B6 strain peak that occurs at POD 18 in strain Pi standard plot is 
much more attenuated compared to the amplitude change seen in the AJ and C3 
strains and is almost none existent for the Complex I genes in set [5,5,3]. Pi standard 
plot in [5,5,3] stays continually down regulated throughout the fracture healing 
process. 
These profiles show up repeatedly in many of the following sets. The 
characteristic peaks that describe these two sets will be referred to as “the 
traditional strain profiles” and only deviations will be highlighted. 
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Figure 17 Genes that tracked across strains 
Set [5,1,5] - All strains show an increase Pi/Ctrl from POD 14 to POD 18. The mean Pi standard 
score expression for AJ and C3 strains show a later peak than the Ctrl group (POD 14 vs POD 
18). The B6 Pi group peaks even later (POD 21) and the amplitude is attenuated. Set [5,1,3] is 
comprised of primarily NADH dehydrogenase genes. AJ and C3 strains have standard score plot 
that are very similar to the TCA expression shown in set [5,1,5]. The B6 strain standard score Pi 
expression for Complex I is more has a more attenuated than TCA, showing a very mild increase 
at POD 18 and a much flatter profile compared the TCA.. 
 46 
3.2.2 Pairwise Comparisons 
Looking at the pairwise comparisons of 48 unique genes related to oxidative 
phosphorylation (Figure 18), the majority of the genes (29) showed up all three 
pairwise comparisons. Recall that 17/29 of these genes already showed up in the all 
strain tracking. Majority of the genes that showed up in all three comparisons were 
related to Complex I (NADH:ubiquinone Oxidoreductase – the grey subunits in 
Complex I Figure 15). The pairwise comparisons were conducted to show which 
strains had gene expressions that were more similar. We computed 68% (33/48), 
75% (36/48), and 94% (45/48) of the 48 unique genes related to oxidative 
phosphorylation clustered similarly between B6/C3, AJ/B6, and AJ/C3, respectively. 
 
Figure 18 Pairwise Comparisons Venn diagram 
This venn diagram illustrates the number of genes that were identified in each pairwise 
comparison and how these 48 unique genes overlapped in between the comparison. 
3.2.3 Pairwise AJ/B6 
The AJ/B6 pairwise comparison identified 4 sets, [5,5,x], [5,1,x], [6,2,x], and 
[6,5,x]  that were each a heterogonous mix of genes related to various components 
of the ETC. [5,5,x] and [5,5,x] were composed of  predominately Complex I (Figure 
19). All three strains had Pi/Ctrl and standard score gene expression profiles that 
exemplified “the traditional strain profiles” highlighted in set [5,1,5]. The magnitude 
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of the expression is slightly attenuated and the profiles are not as congruent as the 
genes identified in the all strain comparisons. 
In set [6,2,x] (Figure 20), all three strains expressed a profile different than 
the “the traditional strain profiles” previously described. These genes were 
predominately related to Complex IV: Cytochrome C Oxidase and showed a flatter 
Pi/Ctrl and standard score expression profiles that did not have any of the 
traditional peaks. Set [6,5,x] (Figure 20) does exemplify the “the traditional strain 
profiles” and the B6 strain expression shows the most congruency amongst all the 
strains with the features highlighted in the [5,1,5] set. The AJ strain and C3 gene 
expression profiles are less tightly clustered than the B6 expression. The Pi/Ctrl 
ratio plots shows the traditional multi-peak features described in set [5,1,5] (peaks 
at POD 17 & POD 18 for AJ strain and POD 10 & POD 18 for C3), however, there is 
more variation around the POD 18 peak. The standard plots for the AJ and C3 strains 
show that as a set, the Pi and Ctrl group exhibit very similar patterns to the “the 
traditional strain profiles”  in set [5,5,3]. 
 48 
 
Figure 19 AJ/B6 Pairwise Comparison (1/2) 
Most of the genes in [5,5,x] and [5,1,x] are related to Complex I. For both sets, the Pi/Ctrl and 
standard score plots for show similar temporal profiles to Complex I genes shown in Figure 17. 
The AJ and C3 strains Pi standard score plots display a similar a temporal shift in expression 
compared to their respective Ctrl group expression. 
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Figure 20 AJ/B6 Pairwise Comparison (2/2) 
Set [6,2,x] is comprised of genes relating primarily to Complex IV. The Ctrl and Pi standard 
score plots illustrate temporally similar expression profiles. Half of set [6,5,x] is comprised of 
genes that comprise Complex I. There are features similar to profiles described in Figure 19, but 
the Pi/Ctrl plot shows coordination, most likely due to the heterogeneous mix of genes. 
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3.2.4 Pairwise AJ/C3 
The AJ/C3 pairwise comparison captured 94% of all the genes identified in 
all pairwise comparisons in 6 separate sets (Figure 21 & Figure 22). Similar to the 
AJ/B6 comparisons, the AJ/C3 sets contained a heterogeneous mix of genes related 
to various components of the ETC. Specifically, sets [6,x,2], [6,x,3], [6,x,5] (Figure 
21), and [5,x,2] (Figure 22) did not have a predominate complex present.  [6,x,2] is 
does have a minority of groups related to Complex IV: Cytochrome C oxidase, some 
of the same genes identified in [6,2,x]. The Pi/Ctrl ratio that oscillates closer to one 
indicates that the Pi and Ctrl ratio have similar expression levels throughout the 
fracture healing. 
Sets [5,x,3] and [5,5,5] were comprised of a large number of genes related to 
Complex I and exemplified “the traditional strain profiles” of set [5,5,3] (Figure 22). 
It is of note that many of these genes were clustered together in the AJ and C3 
strains, but there was bifurcation in the B6 clustering. 
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Figure 21 AJ/C3 Pairwise Comparison (1/2) 
Set [6,x,2] is a heterogeneous mix of genes relating to Complex I and IV and shows a hybrid plot 
of the profiles observed between [6,5,x]  and [6.2,x] (Figure 20). Sets [6,x,3] and [6,x,5] are fairly 
small, but show similar trends to the profiles of Complex I genes described in Figure 17. 
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Figure 22 AJ/C3 Pairwise Comparison (2/2) 
Set [5,x,3] and [5,5,5]] are comprised of genes related to Complex I reiterates the characteristic 
features described by Complex I in the  traditional profiles described for set [5,1,5] Figure 14. 
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3.2.5 Pairwise B6/C3 
Amongst all the pairwise comparisons, the B6/C3 comparison had four sets 
that identified the least amount of genes cluster together. Profiles that were 
identified in the other pairwise comparisons persisted. Set [x,2,2] (Figure 23) was 
comprised of mostly genes related to Complex IV and had flat profiles similar to the 
AJ/B6 set [6,2,x] and AJ/C3 [6,x,2]. This flat profile is seen across all strains and is a 
feature unique to Complex IV. 
Set [x,5,2] (Figure 23) did not have a dominate complex present. The AJ 
strain and C3 profiles were not well defined, having peaks expression around the 
traditional time points identified, but not occurring synchronously. The B6 Pi/Ctrl 
and standard score profiles were most similar to its traditional profile. Sets [6,5,3] 
and [x,5,5] were predominately comprised of genes related to Complex I. These two 
sets followed the traditional expression profiles for all three strains, but the 
amplitude is slightly attenuated. 
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Figure 23 B6/C3 Pairwise Comparison (1/2) 
Set [x,2,2] is mostly comprised of genes related to Complex IV and a flatter expression profiles 
that differs from the traditional expression profiles seen in [5,1,5]. Set [x,5,2] is a mix of multiple 
ETC complexes and displays less coordination over time. Despite the complex heterogeneity, the  
B6 strain standard score expression continues to be distinctly different from the AJ and C3 
strains. 
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Figure 24 B6/C3 Gene Expression Profiles (2/2) 
Set [6,5,3] is related primarily to Complex I and APT Synthase. Set [x,5,5] is more heterogeneous 
in composition, but still contains primarily genes related to Complex I. Both sets display Pi/Ctrl 
and standard score plots that  reiterate the traditional profile features observed for [5,5,3] in 
Figure 17. 
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3.3 Carbohydrate Metabolism 
Under carbohydrate metabolism, starch & sucrose metabolism, and 
glycolysis returned as significant biological functions for the all strain comparisons. 
The pairwise comparisons returned starch & sucrose metabolism, amino sugar & 
nucleotide sugar metabolism, and pyruvate metabolism, for AJ/B6, AJ/C3, and 
B6/C3 comparisons respectively. Only the functions that were identified in the all 
strain comparisons will be investigated from this point forward. 
Glycolysis (Figure 25) and starch & sucrose metabolism (Figure 25) were 
identified in separate clusters. Enolase and Phosphofructokinase (Pfkm), the rate-
limiting step, were two important genes tracked across all strains relating to 
glycolysis. For glycolysis as a whole, AJ and C3 strains had a Pi/Ctrl ratio with two 
distinct peaks, very similar to the Pi/Ctrl profiles seen in the oxidative 
phosphorylation (Figure 25). B6 had a different profile characterized by three peaks 
occurring at POD 10, POD 18, and POD 28.  The Ctrl standard score plots show 
inherent genetic variation. The AJ and C3 strains had very similar profiles that 
decrease expression of these glycolysis genes until POD 10 and peak at POD 14. The 
tail end of the C3 strain expression differs with another peak at POD 21, while AJ 
strain continues an upward trend beyond POD 18 (Figure 25). The B6 strain 
continues to have a different expression profile, exhibiting a downward expression 
longer until POD 18, peaking later than the AJ and C3 strains at POD 21, and then 
decreasing expression again. The Pi expression profiles for all three stains show a 
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strain dependent peak in expression that precedes the Ctrl group (Figure 25). The 
peak in the AJ strain occurs early at POD 5, and later in B6 and C3 strains at POD 14.  
Looking at the standard plots for starch & sucrose (Figure 25), the Pi and Ctrl 
groups had very similar profiles, both increasing over the course of fracture healing. 
 
Figure 25 Glycolysis gene expression profiles. 
Glycolysis genes in both Pi and Ctrl decreased expression during fracture healing; the Pi group 
has an early peak not seen in the Ctrl group. The Pi expression profile for starch and sucrose 
metabolism followed the control profile fairly closely and both increased expression over time. 
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Figure 26 Glycolysis 
This pathway highlights the genes that were identified in the all strain comparisons. 
Phosphofructokinase (Pfkm) is a rate-limiting, irreversible step of glycolysis. High activity 
promotes the conversion of glucose to pyruvate and it is traditionally down regulated in states of 
fasting (Ferrier, 2014). Adapted from IPA, 2016. 
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3.4 Signaling Transduction & Nucleotide Metabolism 
General pyrimidine metabolism was identified only in the all strain 
comparison, and purine metabolism was identified in all comparisons except the 
AJ/C3 pairwise comparison. These gene expression profiles oscillated around a 
Pi/Ctrl ratio of one and hence were not investigated further. mTOR signaling was 
the only significant signaling pathway identified in any of the comparisons (Figure 27 
and Figure 28).  All three strains’ gene expression in set [6,6,2] have a fairly flat 
Pi/Ctrl profile that oscillates at or slightly below 1 (Figure 27).  Neither the Ctrl 
group nor the Pi groups illustrate a discernable trend for the standard scores plots 
(Figure 27). Set [6,4,7] shows more cohesive profiles, particularly for the C3 strain. 
The Pi/Ctrl plots indicate that the Pi expression was higher than Ctrl for majority of 
the healing process. All strains’ Pi expression steadily increased through the fracture 
healing process, except the two genes related to ribosomal protein (rps6k’s) that 
started to drop at POD 18 (Figure 27). 
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Figure 27 mTOR gene expression profiles 
mTOR signaling tracked in two distinct sets: Set [6,6,2] was oscillated very close to 1, indicating 
small differences between Pi and Ctrl expression. Set [6,6,2] did not show any discernable pattern 
of expression in the standard score plots Set [6,4,7] showed an upregulation in the Pi group 
compared to the Ctrl, the first set to have an increased expression in the experimental group. 
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Figure 28 mTOR signaling 
This figure highlights the genes related to mTOR signaling that tracked across all strains. 
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3.5 Amino Acid Metabolism 
Three main pathways related to amino acid metabolism were identified. 
Across all strains, Arginine and Proline metabolism was identified. Essential 
branched chain amino acids (Val, Leu, Ile) and Lysine degradation showed up in all 
three of the pairwise comparisons, and Alanine, aspartate & glutamate metabolism 
only appeared in the AJ/B6 pairwise comparison. The entry points of arginine and 
proline into the TCA cycle are highlighted in Figure 16. This set captured prolyl 4-
hydroxylase, an enzyme necessary for proper folding of collagen in the ER. 
Compared to most other metabolic pathways, the genes captured relating to 
arginine and proline metabolism show less strain variation. Looking at the Ctrl and 
Pi standard plots (Figure 29), all of the Ctrl plots show a similar downward trend 
across all the strains. The Pi expression shares this downward trend, but has 
periodic rebounding with time. Temporally these rebounds occur almost 
synchronistical at POD 18amongst all three strains; the only deviation is the first 
rebound in the B6 strain occurs later than AJ and C3 at POD 10. 
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Figure 29 Arginine and proline gene expression profiles. 
P4ha1 and P4ha2 are subunits of proline 4-hydroxylase, a key enzyme that hydroxylates proline 
residues in collagen, a necessary post-translational modification to properly assemble collagen. 
All three strains Pi group had a peak in expression at POD 18 that was not observed in the Ctrl 
group. 
3.6 Lipid Metabolism 
Only two lipid metabolism pathways were identified across all four 
comparisons. AJ/B6 pairwise comparison identified general fatty acid metabolism, 
and almost all the genes that were identified also played a role in essential branched 
chain degradation and will not be investigated as a separate topic. The B6/C3 
comparison identified six unique genes that were related to glycerophospholipid 
metabolism and were not investigated further. 
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4 DISCUSSION 
4.1 Study Findings 
This study focused on the changes in intermediate metabolism that were 
differentially expressed in a phosphate deficient mouse model that underwent 
femur fracture and subsequent healing. The normal mixtures clustering approach 
was used to group genes with similar temporal profiles. This would identify gene 
sets that are similarly perturbed by the phosphate deficiency. When looking at 
metabolism, the primary functions that were identified to track invariantly across 
all three strains were related most directly to oxidative phosphorylation, 
tricarboxylic acid cycle, and pyruvate dehydrogenase. Pathways relating to 
glycolysis, arginine and proline metabolism, and nucleotide metabolism were also 
identified in these comparisons, but none were as apparent as the oxidative 
phosphorylation. Looking at the profiles for the genes that were found to cluster 
together for oxidative phosphorylation, it was found that expression during fracture 
healing is both complex and strain dependent. 
Analysis of the temporal expression profiles for genes related to oxidative 
phosphorylation found that expression during fracture healing is both strain and 
complex dependent. This phenomenon is illustrated by two recurring profiles that 
emerged throughout the comparisons. The first profile was coined the “traditional 
expression profiles”, best illustrated by Pi/Ctrl and Standard Score plots shown in 
Figure 17. The genes that comprised these two sets were mostly related to pyruvate 
dehydrogenase, TCA (all genes in Figure 16), Complex I: NADH Ubiquinone 
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Reductase, and ATP Synthase Figure 15).  Genes that were related to Complex I were 
most prominent in the pairwise comparisons (AJ/B6 (Figure 19 and Figure 19), 
AJ/C3 (Figure 22) and B6/C3 (Figure 24). 
The Ctrl standard score plots illustrate inherit genetic variation in gene 
expression related to and the Pi standard score plots illustrate strain dependent 
responses to the phosphate deficiency. In comparing these patterns, (A) the Ctrl 
expressions for the AJ and C3 stains had similar profiles to each other and the 
expression of these genes responded in a similar manner to Pi restriction. 
Reintroduction of phosphate at POD 14 further exemplified these strain specific 
variations.  When phosphate was replenished in AJ and C3 strains, the Pi groups 
show delayed peak expression at POD 18, indicating that the phosphate may directly 
help upregulate expression and/or abolish the delay that was being experienced 
during phosphate deficiency. In contrast, the B6 strain Pi group reaches a peak at a 
later time point (POD 21), and the expression do not ever achieve the same 
magnitude of expression shown by the B6 Ctrl group, like the AJ and C3 strains do. 
Genes relating to Complex IV: Cytochrome c oxidase (grey components in 
Complex IV Figure 15) showed less coordination of expression compared to 
Complex I (AJ/B6 (Figure 20), AJ/C3 (Figure 21), and B6/C3 (Figure 23). The Pi/Ctrl 
ratio that oscillates closer to one indicates that the Pi and Ctrl ratio have similar 
expression levels throughout the fracture healing. This is seen across all strains and 
has been unique to Complex IV.   
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In opposition to the energy metabolism, lipid metabolism and signaling were 
the categories that tracked the least across all three strains. Amino acid had very 
specific components regulated across all three strains including: Essential branched 
chain amino acids and arginine and proline metabolism. Notably, two subunits of 
prolyl 4-hydroxylasee, an enzyme necessary for hydroxylation of proline, tracked 
across all three strains under Arginine and Proline Metabolism. 
4.2 Integration of Multiple Branches 
Many of the functions that were identified to track together across all three 
strains are processes that including glycolysis, pyruvate dehydrogenase, Complex IV 
of the electron transport chain, arginine and proline metabolism are directly 
affected by the transcription factor HIF1-α. It has been shown that HIF1-α promotes 
transcription that affects multiple points of metabolism, including: (1-2) Glut1, 
Glut3, and PFK2 to allow an increase uptake and processing of glucose, (3) lactate 
dehydrogenase A to thus shunt the pyruvate away from TCA, and (4) pyruvate 
dehydrogenase kinase (PDK1) that stops the conversion of pyruvates to acetyl CoA. 
(5) HIF-1 also shifts the composition of Complex IV from primarily Cox4-1 subunits 
to Cox4-2 subunits (Figure 30)  (Fukuda et al., 2007; Kim, Tchernyshyov, Semenza, 
& Dang, 2006; Ren et al., 2008; Semenza, 2007).  
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Figure 30 HIF1-α Regulation of Metabolism 
This figure illustrates the points of regulation that HIF1-α affects intermediate metabolism. During 
hypoxic conditions, HIF1-α promotes changes that increase glycolysis without increasing the amount 
of reducing equivalents produced by TCA (Ren et al., 2008) . It also modifies the composition of 
Complex IV to optimize transfer of electrons to O2 at lower oxygen levels (Fukuda et al., 2007). 
Figure from Semeza, 2006. 
Fukuda et al. hypothesizes that this change in subunit composition is necessary to 
fine tune the rate of electron transfer to oxygen at the end of the electron transport 
chain to prevent build up at previous complexes and to minimize production of 
radical oxygen species (ROS) (Fukuda et al., 2007). The mechanism that shifts the 
compositions of Complex IV does so by increasing degradation of subunit cox4-1 
proteins rather than decreasing gene transcription (Fukuda et al., 2007); this may 
explain why Complex IV has a Pi/Ctrl expression profile that is closer to 1 and 
differs from the profiles shown for Complex I. 
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In addition to regulating metabolism during hypoxic conditions, HIF1-α also 
plays a crucial role in regulating the production of collagen (Bentovim, Amarilio, & 
Zelzer, 2012) as well as angiogenesis.  It has been found to increases the expression 
of collagen prolyl 4-hydroxilase (cP4H), a necessary enzyme for hydroxylation of 
pro-collagen in the endoplasmic reticulum (Bentovim et al., 2012).  
Comparing gene sets that comprise functions regulated by HIF1-α (Glycolysis 
– [2,3,4], TCA - [5,1,5], Complex I - [5,5,3], Complex IV – [6,x,2], and Arginine and 
Proline Metabolism – [1,8,6]), we can see that all of the functions are regulated 
similarly over time in both the Pi and Ctrl group (Figure 31). Glycolysis and prolyl 
4-hydroxylase peak earlier than electron transport chain.  The expression levels of 
oxidative phosphorylation in the Pi groups are attenuated compared to the Ctrl 
expression and peak expression is shifted from POD 14 to POD 18. It is also of 
importance that these peaks all occur after the re-introduction of phosphate at POD 
14. The B6 strain expression differs from AJ and C3 with regard to ETC (Complex I 
and IV) expression; the amplitude for these functions is attenuated through the 
entire timeline and do not seem to fully recover. Another point to note, lactate 
dehydrogenase was identified in the B6/C3 pairwise comparison and was 
synchronous with the TCA and ETC temporal plots (not shown below). This is 
important to shunting the pyruvate produced in glycolysis away from TCA. 
This coordination over time suggests that the phosphate deficiency affects 
fracture healing through HIF1-α. HIF1-α is continually expressed and its 
degradation is regulated by prolyl hydroxylases (PHD1-3) that are members of the 
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2-oxogluterate (α-ketoglutarate) dependent dioxygenases (2-OGDO) family (Figure 
32) (Salminen, Kauppinen, & Kaarniranta, 2015). Levels of α-ketoglutarate, oxygen 
tension and the redox status of Fe2+ regulate the activity levels 2-OGDOs and allow 
the enzymes to act as sensors of cell hypoxia and energy levels. Proly-4-hydroyxlase 
(P4H), α-ketoglutarate dehydrogenase (OGFOD1), and prolyl hydroxylases (PHD1-
3) are all members of the 2-OGDO family (Figure 33) (Salminen et al., 2015). In 
2000, Rodriguez-Zavala et al found that inorganic phosphate increased the activity 
of 2-oxogluterate dehydrogenase by increasing the affinity for α-ketoglutarate 
(Rodríguez-Zavala, Pardo, & Moreno-Sánchez, 2000). This same principle may be 
applicable to PHD1-3 and may be the link between phosphate and activity of HIF1- 
α. However, further investigations of the expression levels under HIF1- α are 
necessary to substantiate this hypothesis. 
 
Figure 31 Integration of HIF1-α Metabolic Functions 
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Figure 32 Regulation of HIF 
Prolyl hydroxylases (PDH1-3) degrades HIF1-α during normal oxygen levels, but during 
hypoxia, the loss of oxygen prevents hydroxylation and therefore HIF1-α is expressed during 
hypoxia. From Semeza, 2006 
 
Figure 33 Mechanisms of oxogluterate-dependent dioxygenases 
The blue box highlights examples of 2-OGDOs, the red sox are substances that decrease the 
activity of 2-OGDOs, and orange are the necessary products and reactants that are produced by 
the reaction. From Salminen,2006 
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4.3 Future Directions 
The Normal mixtures clustering method captured expression profiles that 
had similar changes in the expression over time between the control group and the 
Pi group. It captured the temporal shift for genes related to Glycolysis, TCA, 
Pyruvate dehydrogenase, and ETC (Complex I and IV). The B6 strain mice showed 
different expression relative to the AJ and C3 strains with more constant down 
regulation of the electron transport chain. .  
However, Normal Mixtures clustering method does not account for 
interaction between time points. This is important because the time points 
investigated are separated by non-uniform intervals. Using methods (polynomial 
clustering) that focus more on the time interaction component may reduce noise 
and accurately capture more gene that have a temporal shift (Zolhavarieh, 
Aghabozorgi, & Teh, 2014). Secondly, this analysis only looked at a very specific 
scope of metabolic genes that were differentially expressed between the phosphate 
and control group. Moving forward, we would like to expand our investigation to 
look at the HIF1-α expression and bone formation may allow us to help align the 
temporal shifts captured in oxidative phosphorylation with stages of the fracture 
healing process. This study provides new information regarding regulation of 
oxidative phosphorylation during phosphate deficient fracture healing and is an 
important part of eluting the larger mechanisms that underlies phosphate’s role in 
fracture healing. 
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applied for the OVP elective because I think it is 
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important to uplift the members of a marginalized 
community. I am gaining tangible experience on how to 
secure food for the van & establishing oneself as a 
health resource for the homeless in Boston.  
 April 2015 – Present Mentor & Academic Tutor  (100 hours) 
  SquashBusters, Inc. – Escondido, CA 
I volunteer weekly as an academic tutor and mentor 
with Squashbusters in Boston. I work one on one with 
students to build critical thinking skills and a 
foundation in math and science. I also helped guide high 
school juniors/seniors through the college application 
process and assist with writing college application 
essays. 
 Sept 2013 – Aug 2014 Pathmaker Intern   (300 hours) 
  Palomar Health – Escondido, CA 
I served in several departments over my year including: 
acute cardiovascular care, post-anesthesia care, and 
endoscopy/outpatient surgery. I learned about how 
each department operated on a daily basis and got 
exposure to the patient population that the department 
treats.  
I had specific duties in each department; almost all of 
them were to help the patient directly in one form or 
another. I helped patients to eat, to use the bathroom, or 
to walk under the aid of a gate belt. I also took vitals and 
patient information, set up EKG’s (teleboxes) on 
cardiovascular patients, helped nurses with wound 
care, and was fortunate to observe a few colonoscopies 
and laparoscopic knee surgeries.  
 Sept. 2012 – June 2013 Lacrosse Coach   (100 hours) 
  Santa Fe Christian High School – Solana Beach, CA 
I have always wanted to coach and this was the perfect 
a way to give back to my community through a sport 
that has given me so much pride as an individual. I 
created daily practice plans team, coordinated our pre-
season lacrosse tournaments, and set up a community 
service projects for the team. 
 Sept 2007 - June 2011 UC San Diego Lacrosse Player (3,120 hours) 
  UCSD Tritons Lacrosse Team – La Jolla, CA 
 Jan. 2010 – Sept 2011 Treasurer Pi Kappa Alpha Fraternity 
  Kappa Phi Chapter – La Jolla, CA 
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I collected dues from members of the fraternity, created 
and managed budgets for chapter spending, paid all 
chapter expense, and filled the chapter’s non-profit 
taxes. I also helped to recruit sponsors for our 
philanthropy event: Pike Madness Basketball 
Tournament that supports the San Diego Firefighters 
Relief Association. I authored the Treasurer’s handbook 
that has help standardize the position and created two 
chair positions to help the treasurer: a fundraising chair 
and a dues collector. 
 Sept. 2011 – June 2012 New Member Educator 
I helped to plan and coordinated a week of recruiting 
events at the beginning of each quarter. I led three 
cohorts of new members through a quarter long 
education program for new fraternity members. 
